Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Fibrinogen Heterogeneity in Homozygous Plasminogen Deficiency Type I: Further Evidence that Plasmin Is not Involved in Formation of LMW- and LMW’-Fibrinogen

View through CrossRef
SummaryHuman plasma fibrinogen is heterogeneous in SDS-polyacrylamide gel electrophoresis and other methods for separation of proteins by molecular size. A high molecular weight fraction (HMW-fibrinogen, 340 kD) contributes approximately 50% of total fibrinogen antigen. Low molecular weight fibrinogen (LMW-fibrinogen, 300 kD) adds another 40%. The residual amount is LMW’-fibrinogen with a molecular weight of 280 kD, and a small amount of very high molecular weight fibrinogen (Fib420), the product of alternative splicing of the Aa-chain genetic information, resulting in an extended A?-chain C-terminus. Fibrinogen was detected by specific immunostaining of nonreduced SDS-PAGE gel immunoblots with antibodies against fibrinopeptide A. Using densitometric scans of the immunoblots we found a ratio of HMW-, LMW- and LMW’-fibrinogen in a patient with homozygous plasminogen deficiency that was similar to the ratio found in immunoblots of plasma from healthy blood donors. Treatment with plasminogen concentrate resulted in a slight decrease of the proportion of HMW-fibrinogen, followed by an increase to 78%. The LMW’- fibrinogen band gained intensity initially, increasing to 11.9% of fibrinogen antigen 6 h after starting plasminogen infusion, but then dropped to levels below detection limit of the immunoblotting assay. LMW-fibrinogen remained constant during the initial 72 h of plasminogen treatment, then dropping to values in the range of 22-25% afterwards. The proportion of HMW-, LMW-, and LMW’-fibrinogen.again reached the initial levels two weeks after starting treatment with plasminogen concentrate. We conclude that plasminogen is not involved in the limited proteolysis leading to formation of LMW-fibrinogen and LMW’-fibrinogen in the absence of a generalized fibrinolytic condition. Fibrinolytic activation may lead to the formation of fibrinogen degradation product X, which appears in a similar position as LMW’- fibrinogen in SDS-PAGE.
Title: Fibrinogen Heterogeneity in Homozygous Plasminogen Deficiency Type I: Further Evidence that Plasmin Is not Involved in Formation of LMW- and LMW’-Fibrinogen
Description:
SummaryHuman plasma fibrinogen is heterogeneous in SDS-polyacrylamide gel electrophoresis and other methods for separation of proteins by molecular size.
A high molecular weight fraction (HMW-fibrinogen, 340 kD) contributes approximately 50% of total fibrinogen antigen.
Low molecular weight fibrinogen (LMW-fibrinogen, 300 kD) adds another 40%.
The residual amount is LMW’-fibrinogen with a molecular weight of 280 kD, and a small amount of very high molecular weight fibrinogen (Fib420), the product of alternative splicing of the Aa-chain genetic information, resulting in an extended A?-chain C-terminus.
Fibrinogen was detected by specific immunostaining of nonreduced SDS-PAGE gel immunoblots with antibodies against fibrinopeptide A.
Using densitometric scans of the immunoblots we found a ratio of HMW-, LMW- and LMW’-fibrinogen in a patient with homozygous plasminogen deficiency that was similar to the ratio found in immunoblots of plasma from healthy blood donors.
Treatment with plasminogen concentrate resulted in a slight decrease of the proportion of HMW-fibrinogen, followed by an increase to 78%.
The LMW’- fibrinogen band gained intensity initially, increasing to 11.
9% of fibrinogen antigen 6 h after starting plasminogen infusion, but then dropped to levels below detection limit of the immunoblotting assay.
LMW-fibrinogen remained constant during the initial 72 h of plasminogen treatment, then dropping to values in the range of 22-25% afterwards.
The proportion of HMW-, LMW-, and LMW’-fibrinogen.
again reached the initial levels two weeks after starting treatment with plasminogen concentrate.
We conclude that plasminogen is not involved in the limited proteolysis leading to formation of LMW-fibrinogen and LMW’-fibrinogen in the absence of a generalized fibrinolytic condition.
Fibrinolytic activation may lead to the formation of fibrinogen degradation product X, which appears in a similar position as LMW’- fibrinogen in SDS-PAGE.

Related Results

α2–plasmin Inhibitor And α2-Macroglobulin-Plasmin Complexes In Plasma. Quantitation By An Enzyme-Linked Immunosorbent Assay
α2–plasmin Inhibitor And α2-Macroglobulin-Plasmin Complexes In Plasma. Quantitation By An Enzyme-Linked Immunosorbent Assay
An enzyme-linked immunosorbent assay has been developed for the quantitation of α2-plasmin inhibitor-plasmin and α2-macroglobulin-plasmin complexes. In this method, the inhibitor-p...
SUMMARY
SUMMARY
SUMMARYThe purpose of the present monograph is to give an account of the distribution of fibrinolytic components in the organism, with special reference to the tissue activator of ...
Plasminogenuria is associated with podocyte injury, edema, and kidney dysfunction in incident glomerular disease
Plasminogenuria is associated with podocyte injury, edema, and kidney dysfunction in incident glomerular disease
ABSTRACT Urinary plasminogen/plasmin, or plasmin(ogen)uria, has been demonstrated in proteinuric patients and exposure of cultured podocytes to p...
The Influence of Age on in vitro Plasmin Generation in the Presence of Fibrin Monomer
The Influence of Age on in vitro Plasmin Generation in the Presence of Fibrin Monomer
<i>Background and Objectives:</i> The components of the fibrinolytic system interact to generate plasmin from its zymogen form, plasminogen. At birth, all the component...
Kinetics Of Plasminogen Activation By Tissue Plasminogen Activator. Role Of Fibrin
Kinetics Of Plasminogen Activation By Tissue Plasminogen Activator. Role Of Fibrin
The activation of human plasminogen (P) by two-chain tissue plasminogen activator (A) was studied in the presence of fibrin films (F) of increasing size and surface density. Initia...
Plasminogenuria is associated with podocyte injury, edema, and kidney dysfunction in incident glomerular disease
Plasminogenuria is associated with podocyte injury, edema, and kidney dysfunction in incident glomerular disease
Abstract Urinary plasminogen/plasmin, or plasmin (ogen) uria, has been demonstrated in proteinuric patients and exposure of cultured podocytes to plasminogen resu...
Physiology of Plasminogen: With Special Reference to Activation and Degradation
Physiology of Plasminogen: With Special Reference to Activation and Degradation
Plasminogen is said to be synthesized in many organs, but the major source of its production is considered to be the liver. The production of plasminogen is observed in fetal life,...

Back to Top